The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

V De Francesco; A Zullo; Cesare Hassan; N Della Valle; L Pietrini; Mf Minenna; S Winn; R Monno; V Stoppino; S Morini; C Panella; E. Ierardi

The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

V De Francesco, A Zullo, Cesare Hassan, N Della Valle, L Pietrini, Mf Minenna, S Winn, R Monno, V Stoppino, S Morini, C Panella, E. Ierardi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

73 Citazioni (Scopus)

Abstract

One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.

Lingua originale	English
pagine (da-a)	322-326
Numero di pagine	5
Rivista	Digestive and Liver Disease
Volume	36
Stato di pubblicazione	Pubblicato - 2004
Pubblicato esternamente	Sì

Keywords

2-Pyridinylmethylsulfinylbenzimidazoles
Amoxicillin
Anti-Bacterial Agents
Anti-Ulcer Agents
Antitrichomonal Agents
Benzimidazoles
Clarithromycin
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Dyspepsia
Female
Helicobacter Infections
Helicobacter pylori
Humans
Male
Middle Aged
Multivariate Analysis
Omeprazole
Patient Compliance
Peptic Ulcer
Prospective Studies
Smoking
Tinidazole
Treatment Outcome

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{5e7c38c5fdc145fd8a3715493c6588c2,

title = "The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study",

abstract = "One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.",

keywords = "2-Pyridinylmethylsulfinylbenzimidazoles, Amoxicillin, Anti-Bacterial Agents, Anti-Ulcer Agents, Antitrichomonal Agents, Benzimidazoles, Clarithromycin, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Dyspepsia, Female, Helicobacter Infections, Helicobacter pylori, Humans, Male, Middle Aged, Multivariate Analysis, Omeprazole, Patient Compliance, Peptic Ulcer, Prospective Studies, Smoking, Tinidazole, Treatment Outcome, 2-Pyridinylmethylsulfinylbenzimidazoles, Amoxicillin, Anti-Bacterial Agents, Anti-Ulcer Agents, Antitrichomonal Agents, Benzimidazoles, Clarithromycin, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Dyspepsia, Female, Helicobacter Infections, Helicobacter pylori, Humans, Male, Middle Aged, Multivariate Analysis, Omeprazole, Patient Compliance, Peptic Ulcer, Prospective Studies, Smoking, Tinidazole, Treatment Outcome",

author = "{De Francesco}, V and A Zullo and Cesare Hassan and {Della Valle}, N and L Pietrini and Mf Minenna and S Winn and R Monno and V Stoppino and S Morini and C Panella and E. Ierardi",

year = "2004",

language = "English",

volume = "36",

pages = "322--326",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "-Roma: Editrice Gastroenterologica Italiana. -Ospedaletto Pisa: Pacini",

}

TY - JOUR

T1 - The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

AU - De Francesco, V

AU - Zullo, A

AU - Hassan, Cesare

AU - Della Valle, N

AU - Pietrini, L

AU - Minenna, Mf

AU - Winn, S

AU - Monno, R

AU - Stoppino, V

AU - Morini, S

AU - Panella, C

AU - Ierardi, E.

PY - 2004

Y1 - 2004

N2 - One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.

AB - One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Amoxicillin

KW - Anti-Bacterial Agents

KW - Anti-Ulcer Agents

KW - Antitrichomonal Agents

KW - Benzimidazoles

KW - Clarithromycin

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Drug Therapy, Combination

KW - Dyspepsia

KW - Female

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Male

KW - Middle Aged

KW - Multivariate Analysis

KW - Omeprazole

KW - Patient Compliance

KW - Peptic Ulcer

KW - Prospective Studies

KW - Smoking

KW - Tinidazole

KW - Treatment Outcome

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Amoxicillin

KW - Anti-Bacterial Agents

KW - Anti-Ulcer Agents

KW - Antitrichomonal Agents

KW - Benzimidazoles

KW - Clarithromycin

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Drug Therapy, Combination

KW - Dyspepsia

KW - Female

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Male

KW - Middle Aged

KW - Multivariate Analysis

KW - Omeprazole

KW - Patient Compliance

KW - Peptic Ulcer

KW - Prospective Studies

KW - Smoking

KW - Tinidazole

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/34670

M3 - Article

SN - 1590-8658

VL - 36

SP - 322

EP - 326

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

ER -

The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo